Skip to content
In deliveryUnited KingdomGoods£53,566,932

Transitional Drugs 7

Published
Published 8 April 2026

Overview

NHS Wales Shared Services Partnership procured transitional drugs that have recently lost exclusivity, with a contract value of £16.8 million awarded on 3 June 2026. The award was made to ten suppliers: Amgen Ltd, Celix Pharma, Celltrion Healthcare, Fresenius Kabi Ltd, Gedeon Richter UK Ltd, Hikma Pharmaceuticals International Ltd, Mercury Pharmaceuticals Ltd, Novartis Pharmaceuticals UK Ltd, Roche Products Ltd, and Vifor Pharma UK Ltd. The procurement is now in delivery.

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£53,566,932
Procedure
Open
SME suitable
Yes
Published
8 April 2026
Questions by
11 May 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£16,804,001
Award date
3 June 2026
Contract period
30 June 2026 → 30 June 2028
Winners
  • Amgen Ltd
  • Celix Pharma
  • Celltrion Healthcare
  • Fresenius Kabi Ltd
  • Gedeon Richter UK Ltd
  • Hikma Pharmaceuticals International Ltd
  • Mercury Pharmaceuticals Ltd
  • Novartis Pharmaceuticals UK Ltd
  • Roche Products Ltd
  • Vifor Pharma UK Ltd

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    30 June 2026

    View notice ↗
  2. Contract

    5 June 2026

    View notice ↗
  3. Contract Notice

    10 April 2026

    View notice ↗
  4. Prior Information Notice

    8 April 2026

    View notice ↗

Contracting authority

  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

    Buyer

    Cardiff, United Kingdom

    GB-NHS: RQF

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Transitional Drugs 7 — won by Amgen Ltd +9 — Skim